Page 100 - 南京医科大学学报自然科学版
P. 100
第43卷第10期
·1426 · 南 京 医 科 大 学 学 报 2023年10月
[9] KAUFMAN A J,PALATT J,SIVAK M,et al. Thymecto⁃ gery[J]. Surg Today,2007,37(3):192-196
my for myasthenia gravis:complete stable remission and [15] SAKAMAKI Y,ODA T,KANAZAWA G,et al. Interme⁃
associated prognostic factors in over 1000 cases[J]. diate⁃term oncologic outcomes after video⁃assisted thora⁃
Semin Thorac Cardiovasc Surg,2016,28(2):561-568 coscopic thymectomy for early⁃stage thymoma[J]. J Tho⁃
[10] VACHLAS K,ZISIS C,RONTOGIANNI D,et al. Thymo⁃ rac Cardiovasc Surg,2014,148(4):1230-1237
ma and myasthenia gravis:clinical aspects and prognosis [16] LIU Q,GU Z,YANG F,et al. The role of postoperative ra⁃
[J]. Asian Cardiovasc Thorac Ann,2012,20(1):48-52 diotherapy for stage Ⅰ/Ⅱ/Ⅲ thymic tumor⁃results of the
[11] ZHANG Y,YU L,KE J. Pathological features and progno⁃ ChART retrospective database[J]. J Thorac Dis,2016,8
sis of thymoma with or without myasthenia gravis[J]. (4):687-695
Front Surg,2022,9:726673 [17] MA K,GU Z,HAN Y,et al. The application of postopera⁃
[12] GU Z,FU J,SHEN Y,et al. Thymectomy versus tumor tive chemotherapy in thymic tumors and its prognostic ef⁃
resection for early⁃stage thymic malignancies:a Chinese fect[J]. J Thorac Dis,2016,8(4):696-704
alliance for research in thymomas retrospective database [18] KUMAR A,GOYAL V,ASAF B B,et al. Robotic thymec⁃
analysis[J]. J Thorac Dis,2016,8(4):680-686 tomy for myasthenia gravis with or without thymoma⁃surgi⁃
[13] WANG H,GU Z,DING J,et al. Perioperative outcomes cal and neurological outcomes[J]. Neurol India,2017,65
and long ⁃ term survival in clinically early ⁃ stage thymic (1):58-63
malignancies:video ⁃ assisted thoracoscopic thymectomy [19] COMACCHIO G M,MARULLI G,MAMMANA M,et al.
versus open approaches[J]. J Thorac Dis,2016,8(4): Surgical decision making:thymoma and myasthenia gravis
673-679 [J]. Thorac Surg Clin,2019,29(2):203-213
[14] CHENG Y J,HSU J S,KAO E L. Characteristics of thy⁃ [收稿日期] 2023-05-31
moma successfully resected by videothoracoscopic sur⁃ (责任编辑:蒋 莉)
(上接第1401页) 「9」 SUZUMORI N,SEKIZAWA A,TAKEDA E,et al. Classi⁃
能力的高效 DNA 纯化磁珠试剂:CN106701737B[P]. fication of factors involved in nonreportable results of non⁃
2020-07-31 invasive prenatal testing(NIPT)and prediction of suc⁃
[7] HU P,LIANG D,CHEN Y Y,et al. An enrichment meth⁃ cess rate of second NIPT[J]. Prenat Diagn,2019,39(2):
od to increase cell⁃free fetal DNA fraction and significant⁃ 100-106
ly reduce false negatives and test failures for non⁃invasive [10] LIN Y,LIANG D,HU P,et al. Application of fetal cell⁃
prenatal screening:a feasibility study[J]. J Transl Med, free DNA enrichment in non-invasive prenatal screening:
2019,17(1):124 experience from a single center in Eastern China[J].
[8] 王皖骏,段红蕾,丁 蔚,等. 基于高通量测序的孕妇外 Chin Med J,2020,134(1):104-106
周血胎儿游离DNA产前检测的失败率及原因分析[J]. [收稿日期] 2023-04-13
中华医学遗传学杂志,2021,38(12):1171-1175 (责任编辑:蒋 莉)